KatzPresident: Paul M. Katz, DO, FACA, received his doctorate in Osteopathic Medicine from Chicago College of Osteopathic Medicine and training in anesthesiology at the Walter Reed Army Medical Center.  He is board certified in addiction medicine, anesthesiology and family practice.  He holds degrees in both chemistry and biology from Youngstown University.  Dr. Katz has served as an advisor for AMPRO, Adirondack-Hudson-Mohawk Medical Peer Review Organization Inc.  He also served within the New York State Society of Anesthesia on the government legal and economic affairs committee as well as the Committee of Ambulatory Surgery.  Dr. Katz currently offers full service family practice in a rural setting with a special emphasis on addiction medicine.


SRD SAMHSA 2018President-Elect & Chair, Education & Program Planning Committee: Steve Daviss, MD, DFAPA, has most recently served as Senior Medical Advisor to the Office of the Chief Medical Officer and Medical Director of the Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Services Administration within the U.S. Department of Health and Human Services, where he focused on the opioid crisis. He served on a number of related task forces and councils, including the HHS Pain Management Task Force, CDC/HRSA Advisory Committee on HIV and Hepatitis, and the Federal Health IT Coordinating Council. He is double-boarded in Psychiatry and in Psychosomatic Medicine, with expertise in the intersection of psychiatry, primary care, health information technology, and healthcare policy. Prior to beginning his service to HHS, he served in numerous leadership positions in clinical, policy, and medical informatics areas, including clinical assistant professor of Psychiatry at University of Maryland, chair of the Department of Psychiatry at University of Maryland Baltimore Washington Medical Center, founding president at Fuse Health Strategies, Chief Medical Informatics Officer at M3 Information, chair of the Parity Accreditation Committee of ClearHealth Quality Institute, and election to Recorder of the Assembly at the American Psychiatric Association in 2017.

Other past advocacy and leadership roles include president of the Maryland Psychiatric Society, chair of the APA Committee on Mental Health Information Technology, chair of the Public Policy Committee and Board of Directors member for the Maryland-DC Society of Addiction Medicine, and APA Assembly Representative for MPS for eight years. In Maryland, he has served on the Health Care Commission’s Health Information Exchange Policy Board, Health Services and Cost Review Commission’s Performance Measurement committee, and Medicaid Pharmacy & Therapeutics Committee. Work on national standards organizations include URAC’s Health Standards Committee for ten years and co-chair of CCHIT’s Workgroup on Behavioral Health Electronic Health Records. Dr. Daviss is co-author of the 2011 book from Johns Hopkins University Press, “Shrink Rap: Three Psychiatrists Explain Their Work.” #HITshrink on Twitter.


AlvanzoImmediate Past President & Chair, Nominating Committee: Anika Alvanzo, MD, MS is an Assistant Professor at Johns Hopkins University School of Medicine. Dr. Alvanzo graduated from George Washington University School of Medicine and Health Sciences and holds a master’s degree in biostatistics from Virginia Commonwealth University. She is a Diplomate of the American Board of Addiction Medicine, a Distinguished Fellow of the American Society of Addiction Medicine (ASAM), and Region V Director for the ASAM Board of Directors.

At Johns Hopkins, Dr. Alvanzo is the Associate Medical Director at Addiction Treatment Services and the Center for Addiction and Pregnancy where she oversees medical care of patients in two comprehensive, outpatient substance use disorder treatment (SUD) programs. From 2011 – 2018, Dr. Alvanzo directed the Substance Use Disorders Consultation Service, a multidisciplinary addiction consultation service providing clinical consultation, brief intervention and treatment linkage services for inpatients with SUDs. Dr. Alvanzo directs the Addiction Medicine Rotation for the Johns Hopkins Urban Health Medicine-Pediatrics and Primary Care Internal Medicine Residency tracks. She has served as an expert on National Institutes of Health (NIH) and Substance Abuse and Mental Health Services Administration (SAMHSA) panels on the role of opioids in chronic pain and integration of recovery-oriented care in hospital and medical settings, respectively, and was both an invited rapporteur and panelist at the National Academies of Sciences, Engineering and Medicine, “Workshop on Integrating Infectious Disease Considerations with Response to the Opioid Epidemic”.


FarahTreasurer: J Ramsay Farah, MD, MPH, earned his B.Sc. and M.D. from the American University of Beirut. He completed his Residency and Fellowship in pediatrics at the University of Maryland in Baltimore. He holds a Master’s in Public Health from the John Hopkins School of Hygiene and Public Health where he also completed his Residency in general preventative medicine, epidemiology.  Dr. Farah commands 38 years of distinguished clinical practice and executive administrative leadership and is the recipient of over 50 awards at the state, national and international levels.  Currently, he is Regional Medical Director, United Healthcare Clinical Services, NE, and Chief Medical Officer at Phoenix of Health and Phoenix Health Center, L.L.C located in Hagerstown, MD.


BureshSecretary: Dr. Megan Buresh is an Assistant Professor of Medicine in the Division of Chemical Dependence at the Johns Hopkins University School of Medicine. She received a Bachelor of Arts in Biochemical Sciences from Harvard University (magna cum laude with highest honors in field), completed medical school at Johns Hopkins University School of Medicine and residency at Brigham and Women’s Hospital. She is board certified in internal medicine and addiction medicine, and certified as HIV specialist by AAHIVM (American Academy of HIV Medicine - AAHIVS).

She is medical director of the Johns Hopkins Bayview Inpatient Addiction Consult Service. She also provides integrated buprenorphine treatment as part of her outpatient primary care practice. Her research interests include public health and addiction, developing and evaluating models to expand office-based opioid treatment, and improving linkages between clinical addiction treatment and community organizations. She is a co-investigator with the ALIVE study at the Johns Hopkins Bloomberg School of Public Health, where she is studying risk factors for opiate overdose and access to naloxone among injection drug users. She is also the Lead Physician for BHLI PCARE mobile buprenorphine treatment site.


joeadamsChair, Public Policy Committee: Joseph A. Adams, M.D. is a graduate of the University of Maryland School of Medicine, and completed an Internal Medicine Residency and Faculty Development Fellowship at the Johns Hopkins Bayview Medical Center. He is a diplomat of the American Board of Internal Medicine and the American Board of Addiction Medicine. Dr. Adams is the Medical Director of BD Health Services, a group of Opioid Treatment Programs in Baltimore, since 2015. He practiced primary care internal medicine in private practice and in Federally Qualified Health Centers, and has served as the Medical Director of a variety of addiction treatment programs in and around Baltimore. Dr. Adams has given hospital grand rounds presentations on office-based treatment of tobacco use disorder. In 1997 he was the President of Smoke Free Maryland, a coalition which successfully advocated for an increase in state tobacco taxes and for smoke free public places in Maryland.


KolodnerPast President: Dr. George Kolodner is a board certified addiction psychiatrist who has specialized in the outpatient treatment of addictions since 1973. He received his M.D. from the University of Rochester in 1967, and completed his psychiatric training at Yale University in 1971. He is currently the Chief Clinical Officer of the Kolmac Outpatient Recovery Centers, which he co-founded in 1973. Dr. Kolodner is the originator of an outpatient rehabilitation model using a 3 hour a day treatment unit, which led to a new level of care known as intensive outpatient or “IOP.” (ASAM Level 2.1). Preceding IOP with ambulatory withdrawal management and following it up with continuing care created an accessible, comprehensive, integrated treatment approach to addictions as an alternative to the traditional, more fragmented treatment strategy. He is active in teaching medical students and residents at Georgetown University Medical School, where he is a Clinical Professor of Psychiatry. He also teaches psychiatric residents at the University of Maryland, where he also is Clinical Professor of Psychiatry.


Olsen NewPast President: Yngvild Olsen, MD, MPH, currently serves as Medical Director of the Institutes for Behavior Resources Inc/REACH Health Services, a comprehensive outpatient Opioid Treatment Program in Baltimore City. She completed her medical training at Harvard Medical School, and internal medicine residency with a year as Primary Care Chief Resident at the Boston Medical Center.  She received a Master’s in Public Health from the Johns Hopkins University Bloomberg School of Public Health as part of a fellowship in General Internal Medicine at the Johns Hopkins School of Medicine.  She has previously served as the Vice President of Clinical Affairs for the Baltimore Substance Abuse Systems, as the Deputy Health Officer for the Harford County Health Department, and as the Medical Director for the Johns Hopkins Hospital’s outpatient substance use treatment services. Dr. Olsen’s advocacy work serving as the President of the Maryland Society of Addiction Medicine (MDSAM), as the President of the Maryland Association for the Treatment of Opioid Dependence (MATOD), and as a member of several boards and councils, including the Maryland Overdose Prevention Advisory Council, the Journey Home Board, Baltimore’s effort to end homelessness, and the National Council on Alcoholism and Other Drug Dependence-Maryland chapter board. She will also proudly serve as a recently elected At-Large Member to the ASAM Board of Directors. 


MartiPast President: Gerald Marti, MD, PhD is a physician scientist (hematologist) who spent the last 30+ years in the US PHS at the NIH and FDA studying hematological malignancy. As part of his recovery program, he was directed to become a member of the American Society of Addiction Medicine (ASAM). As a member of the Maryland ASAM chapter, he has primarily focused his efforts in the area of continuing medical education. Currently as past-president of the Maryland ASAM chapter, he team teaches the FDA mandated risk evaluation and mitigation strategy (REMS) for the use of extended release and long acting opioids: safe use while improving patient care.  His other interests include smoking cessation, screening, brief intervention and referral treatment (SBIRT), the use of naltrexone for extended-release injectable suspension for the treatment of alcoholism, the scientific basis for 12-step programs and medical student education in the field of alcoholism and addiction. He is also interested in the natural history of alcoholism.  Dr. Marti went to Ghana for14 days in May 2014 and met with Ghanaian professionals regarding the addiction, treatment and rehabilitations.  Dr. Marti is on the Recovery Africa Advisory Council and is also board member for the Arise and Flourish Foundation.


Past President: Marc Fishman MD is an addiction psychiatrist and leads Maryland Treatment Centers, a regional behavioral healthcare provider, which offers programs for residential and outpatient treatment for SUDs and co-occurring disorders, for adolescents and adults He is a member of the faculty of the Department of Psychiatry at the Johns Hopkins University School of Medicine. He writes and lectures widely on a variety of topics including youth treatment, placement and treatment matching strategies, medication treatments for addiction and others. His research work has focused particularly on opioid addiction treatment for youth, and more broadly on pharmacotherapies for addiction, as well as models of care and treatment outcomes for youth SUDs. Dr. Fishman served as a co-editor for the most recent editions of ASAM’s Patient Placement Criteria (PPC 3 and PPC2-R), and was the chief editor for the ASAM PPC Supplement on Pharmacotherapies for Alcohol Use Disorders. He is the Chair of the ASAM Adolescent Workgroup. He served as a Past President (2010-12) of the Maryland Society of Addiction Medicine.


Past President: Devang Gandhi, MB,BS, MD, FRCPsych, DFASAM, DFAPA. Dr. Gandhi earned his medical degree and a doctoral degree in psychiatry from India and his membership of the Royal College of Psychiatrists in the United Kingdom. He completed a residency in psychiatry and a fellowship in addiction psychiatry at the University of Maryland School of Medicine. He is board-certified in psychiatry, addiction psychiatry and addiction medicine. After many years serving as a full-time faculty, he remains active in academics as Clinical Associate Professor of Psychiatry and Director of the Addiction Psychiatry and Addiction Medicine Fellowship Programs at the University of Maryland School of Medicine. He has previously served as the Medical Director of the Addiction Service Line at the University of Maryland Medical Center, the Substance Abuse Treatment Programs at the VA Maryland Health Care System, and the Bureau of Behavioral Health at the Howard County Health Department. Currently, he serves as the Medical Director of the Sinai Hospital Addiction Recovery Program and is a Staff Psychiatrist at the Baltimore VA Medical Center. His research has focused on the treatment of opioid dependence and co-occurring mental health and substance use disorders. He is a former editor of The Maryland Psychiatrist and serves as an Assistant Editor of Addiction.